Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 2995-2998

  Larruskain, Julián ^a   Idigoras, Pedro ^a   Marimón, José M ^a,b   Pérez Trallero, Emilio ^a,b,c  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; RNA 16S; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; BRAIN ABSCESS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NOCARDIA; NOCARDIA ABSCESSUS; NOCARDIA ALBOFLAVA; NOCARDIA CARNEA; NOCARDIA CYRIACIGEORGICA; NOCARDIA FARCINICA; NOCARDIA FLAVOROSEA; NOCARDIA NIIGATENSIS; NOCARDIA NOVA; NOCARDIA OTITIDISCAVIARUM; NOCARDIA RHAMNOSIPHILA; NOCARDIA SHIMOFUSENSIS; NOCARDIA SIENATA; NOCARDIA TAKEDENSIS; NOCARDIA VETERANA; NOCARDIOSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SAPINDACEAE; SKIN ABSCESS; URINE CULTURE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NOCARDIA;

EID: 79956311088     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01279-10     Document Type: Article

References (17)

1. Beaman, B. L., M. A. Saubolle, and R. J. Wallace. 1995. Nocardia, Rhodococcus, Streptomyces, Oerskovia, and other aerobic actinomycetes of medical importance, p. 379-399. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of Clinical Microbiology, 6th ed. American Society for Microbiology, Washington, DC.
2. Brown-Elliott, B. A., J. M. Brown, P. S. Conville, and R. J. Wallace, Jr. 2006. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19:259-282.
3. Cercenado, E., et al. 2007. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob. Agents Chemother. 51:1102-1104.
4. Conville, P. S., J. M. Brown, A. G. Steigerwalt, B. A. Brown-Elliott, and F. G. Witebsky. 2008. Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis complex." J. Clin. Microbiol. 46:1178-1184.
5. Glupczynski, Y., C. Berhin, M. Janssens, and G. Wauters. 2006. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin. Microbiol. Infect. 12:905-912.
6. Lai, C. C., et al. 2009. Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species. J. Antimicrob. Chemother. 64:73-78.
7. Martínez, R., S. Reyes, and R. Menéndez. 2008. Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis. Curr. Opin. Pulm. Med. 14:219-227.
8. Muñoz, J., et al. 2007. Clinical and microbiological features of nocardiosis 1997-2003. J. Med. Microbiol. 56:545-550. (Pubitemid 46626575)
9. National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard M24-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
10. Saubolle, M. A., and D. Sussland. 2003. Nocardiosis: review and laboratory experience. J. Clin. Microbiol. 41:4497-4501.
11. Sorrell, T. C., D. H. Mitchell, and J. R. Iredell. 2005. Nocardia species, p. 2916-2924. In J. E. Bennett, G. L Mandell, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Elsevier, Philadelphia, PA.
12. Steingrube, V. A., et al. 1997. Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J. Clin. Microbiol. 35:817-822.
13. Telenti, A., et al. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.
14. Torres, O. H., et al. 2000. Infection caused by Nocardia farcinica: case report and review. Eur. J. Clin. Microbiol. Infect. Dis. 19:205-212.
15. Vera-Cabrera, L., et al. 2010. In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid. Antimicrob. Agents Chemother. 54:2191-2193.
16. Wallace, R. J., Jr., L. C. Steele, G. Sumter, and J. M. Smith. 1988. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob. Agents Chemother. 32:1776-1779.
17. Wallace, R. J. Jr., B. A. Brown, M. Tsukamura, J. M. Brown, and G. O. Onyi. 1991. Clinical and laboratory features of Nocardia nova. J. Clin. Microbiol. 29:2407-2411.